JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JUNE 1, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.2442?guestAccessKey=49ed6d1a-e838-4437-8d88-92f5ae1e1cad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060122
About The Study: This study of all live births in Norway between September 2021 and February 2022 found that infants born to women who received a second or third COVID-19 vaccine dose during the last two trimesters of pregnancy had a lower incidence of SARS-CoV-2 infection within the first four months of life compared with infants born to unvaccinated women.
Authors: Ellen Øen Carlsen, M.D., of the Norwegian Institute of Public Health in Oslo, Norway, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.